Results
1 -
10 of
32Approaching the Treatment of AML from a Biological Perspective, Acute Myelogenous Leukemia Troxacitabine (Troxatyl ???), Deoxynucleoside Analogs In Cancer Therapy L-Nucleosides as Chemotherapeutic Agents, Deoxynucleoside Analogs In Cancer Therapy Investigational Therapy in Acute Myeloid Leukemia: 2001, Acute Leukemias IX Treatment of AML and High Risk MDS at M.D. Anderson: The Lone Star Approach, Acute Leukemias IX Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28??days in patients with advanced solid malignancies, Cancer Chemotherapy and Pharmacology Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells, Cancer Chemotherapy and Pharmacology Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patients, Cancer Chemotherapy and Pharmacology Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts, Cancer Chemotherapy and Pharmacology Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity, Cancer Chemotherapy and Pharmacology